ArticleACS medicinal chemistry letters2024

SARS-CoV-2 Main Protease Inhibitors That Leverage Unique Interactions with the Solvent Exposed S3 Site of the Enzyme.

Lauren R Blankenship et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.